help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erlich, J. H.
Right arrow Articles by Mackman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erlich, J. H.
Right arrow Articles by Mackman, N.
(American Journal of Pathology. 2000;157:1849-1862.)
© 2000 American Society for Investigative Pathology


Regular Articles

Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing Inflammation

Jonathan H. Erlich*, Edward M. Boyle{dagger}, Joanne Labriola*, J. Craig Kovacich*, Richard A. Santucci*, Colleen Fearns*, Elizabeth N. Morgan{dagger}, Wang Yun{dagger}, Thomas Luther{ddagger}, Osamu Kojikawa{dagger}, Thomas R. Martin{dagger}, Timothy H. Pohlman{dagger}, Edward D. Verrier{dagger} and Nigel Mackman*

From The Scripps Research Institute,*
La Jolla, California; the University of Washington,{dagger}
Seattle, Washington; and the Technical University of Dresden,{ddagger}
Dresden, Germany

Functional inhibition of tissue factor (TF) has been shown to improve coronary blood flow after myocardial ischemia/reperfusion (I/R) injury. TF initiates the coagulation protease cascade, resulting in the generation of the serine protease thrombin and fibrin deposition. Thrombin can also contribute to an inflammatory response by activating various cell types, including vascular endothelial cells. We used a rabbit coronary ligation model to investigate the role of TF in acute myocardial I/R injury. At-risk areas of myocardium showed increased TF expression in the sarcolemma of cardiomyocytes, which was associated with a low level of extravascular fibrin deposition. Functional inhibition of TF activity with an anti-rabbit TF monoclonal antibody administered either 15 minutes before or 30 minutes after coronary ligation reduced infarct size by 61% (P = 0.004) and 44% (P = 0.014), respectively. Similarly, we found that inhibition of thrombin with hirudin reduced infarct size by 59% (P = 0.014). In contrast, defibrinogenating the rabbits with ancrod had no effect on infarct size, suggesting that fibrin deposition does not significantly contribute to infarct size. Functional inhibition of thrombin reduced chemokine expression and inhibition of either TF or thrombin reduced leukocyte infiltration. We propose that cardiomyocyte TF initiates extravascular thrombin generation, which enhances inflammation and injury during myocardial I/R.





This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. Pinet, V. Algalarrondo, S. Sablayrolles, B. Le Grand, C. Pignier, D. Cussac, M. Perez, S. N. Hatem, and A. Coulombe
Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes
Mol. Pharmacol., June 1, 2008; 73(6): 1622 - 1631.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Pawlinski, M. Tencati, C. R. Hampton, T. Shishido, T. A. Bullard, L. M. Casey, P. Andrade-Gordon, M. Kotzsch, D. Spring, T. Luther, et al.
Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and Hypertrophy
Circulation, November 13, 2007; 116(20): 2298 - 2306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Jiang, A. Zatta, H. Kin, N. Wang, J. G. Reeves, J. Mykytenko, J. Deneve, Z.-Q. Zhao, R. A. Guyton, and J. Vinten-Johansen
PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2845 - H2852.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Sevastos, S. E. Kennedy, D. R. Davis, M. Sam, P. W. Peake, J. A. Charlesworth, N. Mackman, and J. H. Erlich
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury
Blood, January 15, 2007; 109(2): 577 - 583.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Doukas, W. Wrasidlo, G. Noronha, E. Dneprovskaia, R. Fine, S. Weis, J. Hood, A. DeMaria, R. Soll, and D. Cheresh
Phosphoinositide 3-kinase {gamma}/{delta} inhibition limits infarct size after myocardial ischemia/reperfusion injury
PNAS, December 26, 2006; 103(52): 19866 - 19871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Cozzi, S. Hazarika, H. W. Stallings III, W. E. Cascio, R. B. Devlin, R. M. Lust, C. J. Wingard, and M. R. Van Scott
Ultrafine particulate matter exposure augments ischemia-reperfusion injury in mice
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H894 - H903.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Rafiq, M. A. Kolpakov, M. Abdelfettah, D. N. Streblow, A. Hassid, L. J. Dell'Italia, and A. Sabri
Role of Protein-tyrosine Phosphatase SHP2 in Focal Adhesion Kinase Down-regulation during Neutrophil Cathepsin G-induced Cardiomyocytes Anoikis
J. Biol. Chem., July 14, 2006; 281(28): 19781 - 19792.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Steffel, T. F. Luscher, and F. C. Tanner
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
Circulation, February 7, 2006; 113(5): 722 - 731.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Eligini, F. Violi, C. Banfi, S. S. Barbieri, M. Brambilla, M. Saliola, E. Tremoli, and S. Colli
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism
Cardiovasc Res, January 1, 2006; 69(1): 218 - 226.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben
Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury
Eur. Heart J., November 1, 2005; 26(21): 2334 - 2343.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Zhang, X. Liu, J. G. Cogan, M. D. Fuerst, J. A. Polikandriotis, R. J. Kelm Jr., and A. R. Strauch
YB-1 Coordinates Vascular Smooth Muscle {alpha}-Actin Gene Activation by Transforming Growth Factor {beta}1 and Thrombin during Differentiation of Human Pulmonary Myofibroblasts
Mol. Biol. Cell, October 1, 2005; 16(10): 4931 - 4940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Suzuki, T. J. Moraes, E. Vachon, H. H. Ginzberg, T.-T. Huang, M. A. Matthay, M. D. Hollenberg, J. Marshall, C. A. G. McCulloch, M. T. H. Abreu, et al.
Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells
Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 231 - 247.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Raivio, R. Suojaranta-Ylinen, and A. H. Kuitunen
Recombinant Factor VIIa in the Treatment of Postoperative Hemorrhage After Cardiac Surgery
Ann. Thorac. Surg., July 1, 2005; 80(1): 66 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Olivero, C. Eigenbrot, R. Goldsmith, K. Robarge, D. R. Artis, J. Flygare, T. Rawson, D. P. Sutherlin, S. Kadkhodayan, M. Beresini, et al.
A Selective, Slow Binding Inhibitor of Factor VIIa Binds to a Nonstandard Active Site Conformation and Attenuates Thrombus Formation in Vivo
J. Biol. Chem., March 11, 2005; 280(10): 9160 - 9169.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Busch, I. Seitz, B. Steppich, S. Hess, R. Eckl, A. Schomig, and I. Ott
Coagulation Factor Xa Stimulates Interleukin-8 Release in Endothelial Cells and Mononuclear Leukocytes: Implications in Acute Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Loverre, P. Ditonno, A. Crovace, L. Gesualdo, E. Ranieri, P. Pontrelli, G. Stallone, B. Infante, A. Schena, S. Di Paolo, et al.
Ischemia-Reperfusion Induces Glomerular and Tubular Activation of Proinflammatory and Antiapoptotic Pathways: Differential Modulation by Rapamycin
J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2675 - 2686.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A.-L. Hemdahl, E. Falk, P. Thoren, and G. K. Hansson
Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H872 - H877.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Pawlinski, B. Pedersen, G. Schabbauer, M. Tencati, T. Holscher, W. Boisvert, P. Andrade-Gordon, R. D. Frank, and N. Mackman
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia
Blood, February 15, 2004; 103(4): 1342 - 1347.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Colognato, J. R. Slupsky, M. Jendrach, L. Burysek, T. Syrovets, and T. Simmet
Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells
Blood, October 1, 2003; 102(7): 2645 - 2652.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Kaur, R. C. Woodman, and P. Kubes
P38 MAPK: critical molecule in thrombin-induced NF-kappa B-dependent leukocyte recruitment
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1095 - H1103.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. W. Klarenbach, A. Chipiuk, R. C. Nelson, M. D. Hollenberg, and A. G. Murray
Differential Actions of PAR2 and PAR1 in Stimulating Human Endothelial Cell Exocytosis and Permeability: The Role of Rho-GTPases
Circ. Res., February 21, 2003; 92(3): 272 - 278.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. J. Chong, T. H. Pohlman, C. R. Hampton, A. Shimamoto, N. Mackman, and E. D. Verrier
Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury
Ann. Thorac. Surg., February 1, 2003; 75(2): S649 - 655.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
C. Kluft, R. Kleemann, and M.P.M. de Maat
How best to counteract the enemies? By controlling inflammation in the coronary circulation
Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G53 - G65.
[Abstract] [PDF]


Home page
BloodHome page
D. Bonderman, A. Teml, J. Jakowitsch, C. Adlbrecht, M. Gyongyosi, W. Sperker, H. Lass, W. Mosgoeller, D. H. Glogar, P. Probst, et al.
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque
Blood, April 15, 2002; 99(8): 2794 - 2800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. T. Beranek
Tissue Factor Identifies Cardiomyocyte Apoptotic Bodies in Reperfusion Injury
Am. J. Pathol., April 1, 2002; 160(4): 1543 - 1544.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. H.M Moons, M. Levi, and R. J.G Peters
Tissue factor and coronary artery disease
Cardiovasc Res, February 1, 2002; 53(2): 313 - 325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Kaur, R. C. Woodman, L. Ostrovsky, and P. Kubes
Selective recruitment of neutrophils and lymphocytes by thrombin: a role for NF-{kappa}B
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H784 - H795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.